Skip to main content

Caxton Corp

SEC CIK
0001388551
Latest filing
Aug 13, 2026

Holdings in Q2 2024

Holdings as of Jun 30, 2024, filed Aug 14, 2024. Long positions only; changes compare share counts with Q1 2024.

Institution overview
Positions
12
+1 vs. Q1 2024
Portfolio value
$19.7M
+$2.18M (+12.4%) vs. Q1 2024
Filed
Aug 14, 2024
SEC
Holdings of Caxton Corp in Q2 2024
SecurityClassSharesValue% of portfolioShare changeActionHistory
XERSXeris Biopharma Holdings, Inc.COM5,113,348$11.5M58.3%00.0%UnchangedHistory
RZLTRezolute, Inc.COM NEW1,318,967$5.67M28.7%00.0%UnchangedHistory
SPYSPDR S&P 500 ETF TrustETF1,869$1.02M5.2%+13+0.7%AddedHistory
BRK.BBerkshire Hathaway IncStock1,025$417.1K2.1%+6+0.6%AddedHistory
LXEOLexeo Therapeutics, Inc.COM17,851$286.3K1.5%+7,532+73.0%AddedHistory
DFTXDefinium Therapeutics, Inc.Stock30,383$219.1K1.1%+1,318+4.5%AddedHistory
ABVXAbivax S.A.SPONSORED ADS13,900$183.8K0.9%−1,908−12.1%ReducedHistory
KYTXKyverna Therapeutics, Inc.COM22,981$172.4K0.9%+7,135+45.0%AddedHistory
MTEMMolecular Templates, Inc.COM NEW136,866$157.4K0.8%00.0%UnchangedHistory
CMPXCompass Therapeutics, Inc.COM43,465$43.5K0.2%00.0%UnchangedHistory
CNTXContext Therapeutics Inc.COM18,403$36.9K0.2%+18,403NewHistory
ACETAdicet Bio, Inc.COM17,488$21.2K0.1%00.0%UnchangedHistory